drugset / Trial / NCT00355953
Vascular and Skeletal Protective Effects of Genistein in Postmenopausal Women
RandomizedParallel-groupDouble-blindTreatment
Summary
The present research program is proposed deepening some pharmacological effects of the genistein therapy in order to individualize alternative treatments to the conventional hormonal replacement therapy useful to reduce the cardiovascular morbidity and mortality and the osteoporotic consequences in postmenopausal women.
Timeline
- Start
- 2003-01
- Primary completion
- —
- Completion
- 2005-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Genistein | Other / unclassified | 54 mg | — |
Indications
No indication recorded.